0135-0200 : Abreva 100 mg/g Topical Cream
NDC: | 0135-0200 |
Labeler: | Glaxosmithkline Consumer Healthcare Lp |
Product Type: | Human OTC Drug |
Drug Name: | Abreva |
Dosage Form: | Topical Cream |
Application #: | NDA020941 |
Rev. Date: |
NDC Package Codes:
- 0135-0200-01: 2 G IN 1 TUBE (0135‑0200‑01)
- 0135-0200-03: 2 G IN 1 BOTTLE, PUMP (0135‑0200‑03)
- 0135-0200-04: 2 TUBE IN 1 PACKAGE (0135‑0200‑04) > 2 G IN 1 TUBE
- 0135-0200-05: 2 TUBE IN 1 PACKAGE (0135‑0200‑05) > 2 G IN 1 TUBE
- 0135-0200-06: 3 BOTTLE, PUMP IN 1 PACKAGE (0135‑0200‑06) / 2 G IN 1 BOTTLE, PUMP
Active Ingredients:
- Docosanol
Dosage Strength:
- 100 mg/g
Related Products:
Based on records with the same trade name.- 0135-0300 Abreva 100 mg/g Topical Cream by Glaxosmithkline Consumer Healthcare Holdings (Us) LLC
- 50090-3476 Abreva 100 mg/g Topical Cream by A-s Medication Solutions
- 63379-056 Abreva 100 mg/g Topical Cream by Glaxo Operations Uk Ltd
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0135-0199Next: 0135-0201 >
Related Discussions:
Docosanol Drug Information
Can anyone provide information regarding Docosanol's use case or mechanism of action? ## Docpsanol is a saturated fa... 1 reply
Can anyone provide information regarding Docosanol's use case or mechanism of action? ## Docpsanol is a saturated fa... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.